Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)

• Status: Completed
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to compare the efficacy of two photosensitizers, methyl-aminolaevulinate (MAL) and 5-aminolaevulinic nanoemulsion (BF-200 ALA) in the treatment of facial actinic keratosis. We use randomized, double-blinded prospective study design. The efficacy will be assessed clinically, histopathologically and immunohistochemically.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Joint Authority for Päijät-Häme Social and Health Care
• Treatments: Aminolevulinic Acid; Methyl 5-aminolevulinate; Photosensitizing Agents

Criteria

Inclusion Criteria:

• actinic keratoses symmetrically on face or scalp

• age over 18 years

• there must be at minumum one ak sized 6mm2 symmetrically on both sides

• patients must be able to make the decision to attend independently

Exclusion Criteria:

• pregnancy

• lactation

• lack of compliance